Daxdilimab (HZN-7734)

daxdilimab · Amgen

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Daxdilimab (HZN-7734), covering 2024-09-19 to 2025-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Study of Daxdilimab (HZN-7734) in Participants With Active Proliferative Lupus Nephritis (LN) [Phase 2]